Ovarian cancer example: h(t rx, age) = h(t) exp(β1 rx + β2 age) > cph1 = coxph(surv(futime, fustat)~rx+age, ovarian) > summary(cph1)
|
|
- Matilda Lee
- 5 years ago
- Views:
Transcription
1 Ovarian cancer example: h(t rx, age) = h(t) exp(β1 rx + β2 age) > cph1 = coxph(surv(futime, fustat)~rx+age, ovarian) > summary(cph1) coxph(formula = Surv(futime, fustat) ~ rx + age, data = ovarian) rx age rx age Rsquare= (max possible= ) Likelihood ratio test= 15.9 on 2 df, p= Wald test = 13.5 on 2 df, p= Score (logrank) test = 18.6 on 2 df, p=9.34e-05 The coxph() function gives you the hazard ratio for a one unit change in the predictor as well as the 95% confidence interval. Also given is the Wald statistic for each parameter as well as overall likelihood ratio, wald and score tests. What if we wanted to estimate hr (rx = 1, age = 50 : rx = 2, age = 60)? The point estimate is easily obtained as, exp{ 0.804(1 2) (50 60)} = We can get the variance-covariance matrix for the parameter estimates from the fitted object. > cph1$var [,1] [,2] [1,] [2,] > sqrt(diag(cph1$var)) [1]
2 The 95% CI for hr (rx = 1, age = 50 : rx = 2, age = 60) is, = exp ( ± 1.96 (0.706)) = (0.099, 2.67) Partial likelihood ratio tests What if we want to do a likelihood ratio test for H0 : β2 = 0 in the previous model? Reduced model: >cph1r = coxph(surv(futime, fustat)~rx, ovarian) > summary(cph1r) coxph(formula = Surv(futime, fustat) ~ rx, data = ovarian) rx rx Rsquare= 0.04 (max possible= ) Likelihood ratio test= 1.05 on 1 df, p=0.305 Wald test = 1.03 on 1 df, p=0.310 Score (logrank) test = 1.06 on 1 df, p=0.303
3 > cph1$loglik [1] > cph1r$loglik [1] log L (full model) = log L (reduced model) = X 2 = 2 log L (reduced model) ( 2 log L (full model)) = = > χ1 2 = 3.84 Stratification example Suppose in the previous ovarian cancer example, we stratify by age instead of including it as a predictor in the model. We will create two strata, women over the age of 60 (n=7) and women younger than 60 (n=19). There are 6 events in each group. We fit the following regression model, h(t rx, agegrp) = h agegrp(t) exp(rx β), agegrp = 1, 2. > cph2=coxph(surv(futime, fustat)~rx+strata(age>60), ovarian) > summary(cph2) coxph(formula = Surv(futime, fustat) ~ rx + strata(age > 60), data = ovarian) rx rx Rsquare= 0.02 (max possible= ) Likelihood ratio test= 0.52 on 1 df, p=0.471 Wald test = 0.51 on 1 df, p=0.474 Score (logrank) test = 0.52 on 1 df, p=0.471
4 How does this compare to an additive model with agegrp as a predictor? > cph3=coxph(surv(futime, fustat)~rx+(age>60), ovarian) > summary(cph3) coxph(formula = Surv(futime, fustat) ~ rx + (age > 60), data = ovarian) rx age > 60TRUE rx age > 60TRUE Rsquare= (max possible= ) Likelihood ratio test= 11.8 on 2 df, p= Wald test = 12.2 on 2 df, p= Score (logrank) test = 17.3 on 2 df, p= What about an interaction? > cph4 = coxph(surv(futime, fustat)~rx*(age>60), ovarian) > summary(cph4) coxph(formula = Surv(futime, fustat) ~ rx * (age > 60), data = ovarian) rx age > 60TRUE rx:age > 60TRUE rx age > 60TRUE rx:age > 60TRUE Rsquare= (max possible= ) Likelihood ratio test= 11.8 on 3 df, p= Wald test = 12.1 on 3 df, p= Score (logrank) test = 17.5 on 3 df, p=
5 8.4 Three different treatments were administered to rats who had F98 glioma cells implanted into their brains (Data from Chapter 7 (Exercise 7.7)). The data for the three groups of rats lists the death times (in days) in that exercise. Create two dummy variables, Z1 = 1 if animal is in the radiation only group, 0 otherwise; Z2 = 1 if animal is in the radiation plus BPA group, 0 otherwise. Use the Breslow method of handling ties in the problems below. (a) Estimate β1 and β2 and their respective standard errors. Find a 95% confidence interval for the relative risk of death of an animal radiated only compared to an untreated animal. (b) Test the global hypothesis of no effect of either radiation or radiation plus BPA on survival. Perform the test using all the three tests(wald, likelihood ratio, and score test). (c) Test the hypothesis that the effect a radiated only animal has on survival is the same as the effect of radiation plus BPA (i.e., Test H0: β1 = β2). (d) Find an estimate and a 95% confidence interval for the relative risk of death for a radiation plus BPA animal as compared to a radiated only animal. (e) Test the hypothesis that any radiation given as a treatment (either radiation alone or with BPA) has a different effect on survival than no radiation. Use the likelihood ratio test. (f) Repeat part (e) using a Wald test.
6 Solution: > Ratdata <- read.table(file="ratdata.txt",col.names=c("trtyp","time","dth")) Here, 1 = untreated, 2 = rad, 3 = rad + BPA, actually same data as BNCT >ratcox<coxph(surv(time,dth)~i(trtyp==2)+i(trtyp==3),ratdata,method="breslow") > summary(ratcox) coxph(formula = Surv(time, Dth) ~ I(TrTyp == 2) + I(TrTyp == 3), data = Ratdata, method = "breslow") n= 30 I(TrTyp == 2)TRUE e-03 I(TrTyp == 3)TRUE e-06 I(TrTyp == 2)TRUE I(TrTyp == 3)TRUE Rsquare= (max possible= ) Likelihood ratio test= 27.4 on 2 df, p=1.14e-06 Wald test = 22.4 on 2 df, p=1.34e-05 Score (logrank) test = 31.7 on 2 df, p=1.28e-07 Part (a) > round(c(ratcox$coef, se=sqrt(diag(ratcox$var))),4) I(TrTyp == 2)TRUE I(TrTyp == 3)TRUE se1 se > round(exp(2*(ratcox$coef[1]+c(-1,1)*1.96*sqrt(ratcox$var[1,1]))),4) [1] Part (b) Here, 2df χ 2 test of β1 = β2 = 0 From summary(ratcox): Likelihood ratio test= 27.4 on 2 df, p=1.14e-06 Wald test = 22.4 on 2 df, p=1.34e-05 Score (logrank) test = 31.7 on 2 df, p=1.28e-07
7 Part (c) (d) We want standard error for (β1 hat - β2 hat)*2 = (2,-2) %*% β hat. >c((ratcox$coef %*%c(-1,1) )/sqrt(c(-1,1) %*% ratcox$var %*% c(-1,1))) [1] # highly significant difference: pval > 2*(1- pnorm(2.7588)) [1] > c(estrr = exp(ratcox$coef %*% c(-1,1)), CI=exp(2*(ratcox$coef %*% c(-1,1) + c(-1,1)*1.96*sqrt(c(-1,1) %*% ratcox$var %*% c(-1,1))))) EstRR CI1 CI Part (e) - (f) If we fit using Cox model combining both radiation groups, then >ratcox1<-coxph(surv(time,dth)~ I(TrTyp>1), Ratdata, method="breslow") > summary(ratcox1) coxph(formula = Surv(time, Dth) ~ I(TrTyp > 1), data = Ratdata, method = "breslow") n= 30 I(TrTyp > 1)TRUE e-05 I(TrTyp > 1)TRUE Rsquare= (max possible= ) Likelihood ratio test= 18.9 on 1 df, p=1.36e-05 Wald test = 18.9 on 1 df, p=1.41e-05 Score (logrank) test = 26.2 on 1 df, p=3.12e-07 > ratcoxalt <- coxph(surv(time,dth) ~ I(TrTyp>1), Ratdata, robust=t, method="breslow")
8 > summary(ratcoxalt) coxph(formula = Surv(time, Dth) ~ I(TrTyp > 1), data = Ratdata, method = "breslow", robust = T) n= 30 coef exp(coef) se(coef) robust se z p I(TrTyp > 1)TRUE e-06 I(TrTyp > 1)TRUE Rsquare= (max possible= ) Likelihood ratio test= 18.9 on 1 df, p=1.36e-05 Wald test = 22.6 on 1 df, p=1.97e-06 Score (logrank) test = 26.2 on 1 df, p=3.12e-07, Robust = 14.9 p= (Note: the likelihood ratio and score tests assume independence of observations within a cluster, the Wald and robust score tests do not). > sqrt(c(naive.var=ratcoxalt$naive, Robust.var=ratcoxalt$var)) Naive.var Robust.var Part (e) It seems to ask for test of β1 = 0 OR β2 = 0. We can do it using a Cox-model fit with the combined single covariate = Z1 + Z2.
9 > plot(survfit(ratcox)) > plot(survfit(ratcox1)) > coxhaz <- basehaz(ratcox, FALSE) > coxhaz hazard time Fig 1.1(ratcox) Fig 1.2(ratcox1) Model fitting syntax above is for non time-dependent covariates in Cox model. Timedependent covariate Cox model is also available, but with slightly different data structure: data-frame or list no longer has time and status columns, but instead start, stop, event. This is a counting-process data-structure introduced by Andersen and Gill (1982). (a,b] defines as start = a and stop = b. Syntax of model-fitting becomes: > coxph(surv(start,stop,event) ~ x + strata(reg),data=dfram)
Introduction to Statistical Methods for Clinical Trials
Introduction to Clinical Trials Dalla Lana School of Public Health University of Toronto olli.saarela@utoronto.ca September 1, 2014 16-1 16-2 Clinical A definition (Miettinen 2011, p. 139): intended to
More informationMultivariable Cox regression. Day 3: multivariable Cox regression. Presentation of results. The statistical methods section
Outline: Multivariable Cox regression PhD course Survival analysis Day 3: multivariable Cox regression Thomas Alexander Gerds Presentation of results The statistical methods section Modelling The linear
More informationSupplementary Online Content
Supplementary Online Content Neuhouser ML, Aragaki AK, Prentice RL, et al. Overweight, obesity, and postmenopausal invasive breast cancer risk: a secondary analysis of the Women s Health Initiative randomized
More informationRegression Output: Table 5 (Random Effects OLS) Random-effects GLS regression Number of obs = 1806 Group variable (i): subject Number of groups = 70
Regression Output: Table 5 (Random Effects OLS) Random-effects GLS regression Number of obs = 1806 R-sq: within = 0.1498 Obs per group: min = 18 between = 0.0205 avg = 25.8 overall = 0.0935 max = 28 Random
More informationImmortal Time Bias and Issues in Critical Care. Dave Glidden May 24, 2007
Immortal Time Bias and Issues in Critical Care Dave Glidden May 24, 2007 Critical Care Acute Respiratory Distress Syndrome Patients on ventilator Patients may recover or die Outcome: Ventilation/Death
More informationJoint Modelling of Event Counts and Survival Times: Example Using Data from the MESS Trial
Joint Modelling of Event Counts and Survival Times: Example Using Data from the MESS Trial J. K. Rogers J. L. Hutton K. Hemming Department of Statistics University of Warwick Research Students Conference,
More informationThe SAS SUBTYPE Macro
The SAS SUBTYPE Macro Aya Kuchiba, Molin Wang, and Donna Spiegelman April 8, 2014 Abstract The %SUBTYPE macro examines whether the effects of the exposure(s) vary by subtypes of a disease. It can be applied
More informationChapter 13 Estimating the Modified Odds Ratio
Chapter 13 Estimating the Modified Odds Ratio Modified odds ratio vis-à-vis modified mean difference To a large extent, this chapter replicates the content of Chapter 10 (Estimating the modified mean difference),
More informationCHL 5225 H Advanced Statistical Methods for Clinical Trials. CHL 5225 H The Language of Clinical Trials
CHL 5225 H Advanced Statistical Methods for Clinical Trials Two sources for course material 1. Electronic blackboard required readings 2. www.andywillan.com/chl5225h code of conduct course outline schedule
More informationA Methodological Issue in the Analysis of Second-Primary Cancer Incidence in Long-Term Survivors of Childhood Cancers
American Journal of Epidemiology Copyright 2003 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 158, No. 11 Printed in U.S.A. DOI: 10.1093/aje/kwg278 PRACTICE OF EPIDEMIOLOGY
More informationRapid decline of female genital circumcision in Egypt: An exploration of pathways. Jenny X. Liu 1 RAND Corporation. Sepideh Modrek Stanford University
Rapid decline of female genital circumcision in Egypt: An exploration of pathways Jenny X. Liu 1 RAND Corporation Sepideh Modrek Stanford University This version: February 3, 2010 Abstract Egypt is currently
More informationLandmarking, immortal time bias and. Dynamic prediction
Landmarking and immortal time bias Landmarking and dynamic prediction Discussion Landmarking, immortal time bias and dynamic prediction Department of Medical Statistics and Bioinformatics Leiden University
More informationAnswer all three questions. All questions carry equal marks.
UNIVERSITY OF DUBLIN TRINITY COLLEGE Faculty of Engineering, Mathematics and Science School of Computer Science and Statistics Postgraduate Diploma in Statistics Trinity Term 2 Introduction to Regression
More informationThe Statistical Analysis of Failure Time Data
The Statistical Analysis of Failure Time Data Second Edition JOHN D. KALBFLEISCH ROSS L. PRENTICE iwiley- 'INTERSCIENCE A JOHN WILEY & SONS, INC., PUBLICATION Contents Preface xi 1. Introduction 1 1.1
More informationDaniel Boduszek University of Huddersfield
Daniel Boduszek University of Huddersfield d.boduszek@hud.ac.uk Introduction to Multinominal Logistic Regression SPSS procedure of MLR Example based on prison data Interpretation of SPSS output Presenting
More informationDaniel Boduszek University of Huddersfield
Daniel Boduszek University of Huddersfield d.boduszek@hud.ac.uk Introduction to Logistic Regression SPSS procedure of LR Interpretation of SPSS output Presenting results from LR Logistic regression is
More informationSelf-assessment test of prerequisite knowledge for Biostatistics III in R
Self-assessment test of prerequisite knowledge for Biostatistics III in R Mark Clements, Karolinska Institutet 2017-10-31 Participants in the course Biostatistics III are expected to have prerequisite
More informationApplication of Cox Regression in Modeling Survival Rate of Drug Abuse
American Journal of Theoretical and Applied Statistics 2018; 7(1): 1-7 http://www.sciencepublishinggroup.com/j/ajtas doi: 10.11648/j.ajtas.20180701.11 ISSN: 2326-8999 (Print); ISSN: 2326-9006 (Online)
More information8/6/15. Homework. Homework. Lecture 8: Systematic Reviews and Meta-analysis
Lecture 8: Systematic Reviews and Meta-analysis Christopher S. Hollenbeak, PhD Jane R. Schubart, PhD The Outcomes Research Toolbox Homework Stata Example: stset surv_days, failure(died) sts test age_cat
More informationAnalysis of TB prevalence surveys
Workshop and training course on TB prevalence surveys with a focus on field operations Analysis of TB prevalence surveys Day 8 Thursday, 4 August 2011 Phnom Penh Babis Sismanidis with acknowledgements
More informationBin Liu, Lei Yang, Binfang Huang, Mei Cheng, Hui Wang, Yinyan Li, Dongsheng Huang, Jian Zheng,
The American Journal of Human Genetics, Volume 91 Supplemental Data A Functional Copy-Number Variation in MAPKAPK2 Predicts Risk and Survival of Lung Cancer Bin Liu, Lei Yang, Binfang Huang, Mei Cheng,
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Howard R, McShane R, Lindesay J, et al. Donepezil and memantine
More informationASDA2 ANALYSIS EXAMPLE REPLICATION SPSS C6
ASDA2 ANALYSIS EXAMPLE REPLICATION SPSS C6 * Full Syntax for Analysis Example Replication C6 GET SAS DATA='P:\ASDA 2\Data sets\nhanes 2011_2012\nhanes1112_sub_8aug2016.sas7bdat'. DATASET NAME DataSet2
More informationPackage frailtyhl. February 19, 2015
Type Package Title Frailty Models via H-likelihood Version 1.1 Date 2012-05-04 Author Il Do HA, Maengseok Noh, Youngjo Lee Package frailtyhl February 19, 2015 Maintainer Maengseok Noh
More informationIn this module I provide a few illustrations of options within lavaan for handling various situations.
In this module I provide a few illustrations of options within lavaan for handling various situations. An appropriate citation for this material is Yves Rosseel (2012). lavaan: An R Package for Structural
More informationImpacts of Early Exposure to Work on Smoking Initiation Among Adolescents and Older Adults: the ADD Health Survey. David J.
Impacts of Early Exposure to Work on Smoking Initiation Among Adolescents and Older Adults: the ADD Health Survey David J. Lee, PhD University of Miami Miller School of Medicine Department of Public Health
More informationWorkplace Project Portfolio C (WPP C) Laura Rodwell
Workplace Project Portfolio C (WPP C) Laura Rodwell Project title Modeling the hazard of violent re-offending: An examination of the Andersen-Gill survival analysis model for recurrent events Location
More informationPoisson regression. Dae-Jin Lee Basque Center for Applied Mathematics.
Dae-Jin Lee dlee@bcamath.org Basque Center for Applied Mathematics http://idaejin.github.io/bcam-courses/ D.-J. Lee (BCAM) Intro to GLM s with R GitHub: idaejin 1/40 Modeling count data Introduction Response
More informationEstimating Adjusted Prevalence Ratio in Clustered Cross-Sectional Epidemiological Data
Estimating Adjusted Prevalence Ratio in Clustered Cross-Sectional Epidemiological Data Carlos A. Teles, Leila D. Amorim, Rosemeire L. Fiaccone, Sérgio Cunha,Maurício L. Barreto, Maria Beatriz B. do Carmo,
More informationMLE #8. Econ 674. Purdue University. Justin L. Tobias (Purdue) MLE #8 1 / 20
MLE #8 Econ 674 Purdue University Justin L. Tobias (Purdue) MLE #8 1 / 20 We begin our lecture today by illustrating how the Wald, Score and Likelihood ratio tests are implemented within the context of
More informationDownloaded from jhs.mazums.ac.ir at 13: on Friday July 27th 2018 [ DOI: /acadpub.jhs ]
Iranian Journal of Health Sciences 2016; 4(2): 11-18 Original Article http://jhs.mazums.ac.ir Application of Weibull Accelerated Failure Time Model on the Disease-free Survival Rate of Breast Cancer Narges
More information(a) Perform a cost-benefit analysis of diabetes screening for this group. Does it favor screening?
Cameron ECON 132 (Health Economics): SECOND MIDTERM EXAM (A) Winter 18 Answer all questions in the space provided on the exam. Total of 36 points (and worth 22.5% of final grade). Read each question carefully,
More informationLocoregional treatment Session Oral Abstract Presentation Saulo Brito Silva
Locoregional treatment Session Oral Abstract Presentation Saulo Brito Silva Background Post-operative radiotherapy (PORT) improves disease free and overall suvivallin selected patients with breast cancer
More informationMidterm Exam ANSWERS Categorical Data Analysis, CHL5407H
Midterm Exam ANSWERS Categorical Data Analysis, CHL5407H 1. Data from a survey of women s attitudes towards mammography are provided in Table 1. Women were classified by their experience with mammography
More informationSarwar Islam Mozumder 1, Mark J Rutherford 1 & Paul C Lambert 1, Stata London Users Group Meeting
2016 Stata London Users Group Meeting stpm2cr: A Stata module for direct likelihood inference on the cause-specific cumulative incidence function within the flexible parametric modelling framework Sarwar
More informationJoseph W Hogan Brown University & AMPATH February 16, 2010
Joseph W Hogan Brown University & AMPATH February 16, 2010 Drinking and lung cancer Gender bias and graduate admissions AMPATH nutrition study Stratification and regression drinking and lung cancer graduate
More informationMatched Cohort designs.
Matched Cohort designs. Stefan Franzén PhD Lund 2016 10 13 Registercentrum Västra Götaland Purpose: improved health care 25+ 30+ 70+ Registries Employed Papers Statistics IT Project management Registry
More informationOverview. All-cause mortality for males with colon cancer and Finnish population. Relative survival
An overview and some recent advances in statistical methods for population-based cancer survival analysis: relative survival, cure models, and flexible parametric models Paul W Dickman 1 Paul C Lambert
More informationApplications. DSC 410/510 Multivariate Statistical Methods. Discriminating Two Groups. What is Discriminant Analysis
DSC 4/5 Multivariate Statistical Methods Applications DSC 4/5 Multivariate Statistical Methods Discriminant Analysis Identify the group to which an object or case (e.g. person, firm, product) belongs:
More informationContent. Basic Statistics and Data Analysis for Health Researchers from Foreign Countries. Research question. Example Newly diagnosed Type 2 Diabetes
Content Quantifying association between continuous variables. Basic Statistics and Data Analysis for Health Researchers from Foreign Countries Volkert Siersma siersma@sund.ku.dk The Research Unit for General
More information4. STATA output of the analysis
Biostatistics(1.55) 1. Objective: analyzing epileptic seizures data using GEE marginal model in STATA.. Scientific question: Determine whether the treatment reduces the rate of epileptic seizures. 3. Dataset:
More informationMultivariate dose-response meta-analysis: an update on glst
Multivariate dose-response meta-analysis: an update on glst Nicola Orsini Unit of Biostatistics Unit of Nutritional Epidemiology Institute of Environmental Medicine Karolinska Institutet http://www.imm.ki.se/biostatistics/
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Rawshani Aidin, Rawshani Araz, Franzén S, et al. Risk factors,
More informationPaper #SD42. Zhai, Y., Kahn, K.E., O'Halloran, A., Leidos, Inc., Santibanez, T.A., CDC
Paper #SD42 Comparing Results from Cox Proportional Hazards Models using SUDAAN and SAS Survey Procedures to a Logistic Regression Model for Analysis of Influenza Vaccination Coverage Zhai, Y., Kahn, K.E.,
More informationSupplemental text for. Combining gene signatures improves prediction of breast cancer survival. Contents
Supplemental text for Combining gene signatures improves prediction of breast cancer survival Xi Zhao, Einar Andreas Rødland, Therese Sørlie, Bjørn Naume, Anita Langerød, Arnoldo Frigessi, Vessela N. Kristensen,
More informationStatistical Science Issues in HIV Vaccine Trials: Part I
Statistical Science Issues in HIV Vaccine Trials: Part I 1 2 Outline 1. Study population 2. Criteria for selecting a vaccine for efficacy testing 3. Measuring effects of vaccination - biological markers
More informationName: emergency please discuss this with the exam proctor. 6. Vanderbilt s academic honor code applies.
Name: Biostatistics 1 st year Comprehensive Examination: Applied in-class exam May 28 th, 2015: 9am to 1pm Instructions: 1. There are seven questions and 12 pages. 2. Read each question carefully. Answer
More informationJournal: Nature Methods
Journal: Nature Methods Article Title: Network-based stratification of tumor mutations Corresponding Author: Trey Ideker Supplementary Item Supplementary Figure 1 Supplementary Figure 2 Supplementary Figure
More informationBasic Biostatistics. Chapter 1. Content
Chapter 1 Basic Biostatistics Jamalludin Ab Rahman MD MPH Department of Community Medicine Kulliyyah of Medicine Content 2 Basic premises variables, level of measurements, probability distribution Descriptive
More informationAssessing the effectiveness of the correctional sex offender treatment program
Online Journal of Japanese Clinical Psychology 2016, April, Vol.3, 1-13 Research Article Published on Web 04/20/2016 Assessing the effectiveness of the correctional sex offender treatment program Mana
More informationPackage speff2trial. February 20, 2015
Version 1.0.4 Date 2012-10-30 Package speff2trial February 20, 2015 Title Semiparametric efficient estimation for a two-sample treatment effect Author Michal Juraska , with contributions
More informationSurvival analysis beyond the Cox-model
Survival analysis beyond the Cox-model Hans C. van Houwelingen Department of Medical Statistics Leiden University Medical Center The Netherlands jcvanhouwelingen@lumc.nl http://www.medstat.medfac.leidenuniv.nl/ms/hh/
More informationSession 9. Correlate of Protection (CoP) (Plotkin and Gilbert, CID 2012)
Module 8 Evaluating Immunological Correlates of Protection Session 9 Validation Using Prentice Criteria and Causal Inference Framework, Design Considerations Ivan S.F. Chan, Ph.D. Merck Research Laboratories
More informationDeclaration of Conflict of Interest. No potential conflict of interest to disclose with regard to the topics of this presentations.
Declaration of Conflict of Interest No potential conflict of interest to disclose with regard to the topics of this presentations. Clinical implications of smoking relapse after acute ischemic stroke Furio
More informationUsing Statistical Principles to Implement FDA Guidance on Cardiovascular Risk Assessment for Diabetes Drugs
Using Statistical Principles to Implement FDA Guidance on Cardiovascular Risk Assessment for Diabetes Drugs David Manner, Brenda Crowe and Linda Shurzinske BASS XVI November 9-13, 2009 Acknowledgements
More informationHuman Papillomavirus (HPV) Testing for Normal Cervical Cytology in Low-Risk Women Aged Years by Family Physicians
ORIGINAL RESEARCH Human Papillomavirus (HPV) Testing for Normal Cervical Cytology in Low-Risk Women Aged 30 65 Years by Family Physicians Maria Syl D. de la Cruz, MD, Alisa P. Young, MD, and Mack T. Ruffin
More informationEPI 200C Final, June 4 th, 2009 This exam includes 24 questions.
Greenland/Arah, Epi 200C Sp 2000 1 of 6 EPI 200C Final, June 4 th, 2009 This exam includes 24 questions. INSTRUCTIONS: Write all answers on the answer sheets supplied; PRINT YOUR NAME and STUDENT ID NUMBER
More informationPearce, N (2016) Analysis of matched case-control studies. BMJ (Clinical research ed), 352. i969. ISSN DOI: https://doi.org/ /bmj.
Pearce, N (2016) Analysis of matched case-control studies. BMJ (Clinical research ed), 352. i969. ISSN 0959-8138 DOI: https://doi.org/10.1136/bmj.i969 Downloaded from: http://researchonline.lshtm.ac.uk/2534120/
More informationEffective Implementation of Bayesian Adaptive Randomization in Early Phase Clinical Development. Pantelis Vlachos.
Effective Implementation of Bayesian Adaptive Randomization in Early Phase Clinical Development Pantelis Vlachos Cytel Inc, Geneva Acknowledgement Joint work with Giacomo Mordenti, Grünenthal Virginie
More information1. Objective: analyzing CD4 counts data using GEE marginal model and random effects model. Demonstrate the analysis using SAS and STATA.
LDA lab Feb, 6 th, 2002 1 1. Objective: analyzing CD4 counts data using GEE marginal model and random effects model. Demonstrate the analysis using SAS and STATA. 2. Scientific question: estimate the average
More informationisc ove ring i Statistics sing SPSS
isc ove ring i Statistics sing SPSS S E C O N D! E D I T I O N (and sex, drugs and rock V roll) A N D Y F I E L D Publications London o Thousand Oaks New Delhi CONTENTS Preface How To Use This Book Acknowledgements
More informationTWISTED SURVIVAL: IDENTIFYING SURROGATE ENDPOINTS FOR MORTALITY USING QTWIST AND CONDITIONAL DISEASE FREE SURVIVAL. Beth A.
TWISTED SURVIVAL: IDENTIFYING SURROGATE ENDPOINTS FOR MORTALITY USING QTWIST AND CONDITIONAL DISEASE FREE SURVIVAL by Beth A. Zamboni BS Statistics, University of Pittsburgh, 1997 MS Biostatistics, Harvard
More informationToday: Binomial response variable with an explanatory variable on an ordinal (rank) scale.
Model Based Statistics in Biology. Part V. The Generalized Linear Model. Single Explanatory Variable on an Ordinal Scale ReCap. Part I (Chapters 1,2,3,4), Part II (Ch 5, 6, 7) ReCap Part III (Ch 9, 10,
More informationLOGLINK Example #1. SUDAAN Statements and Results Illustrated. Input Data Set(s): EPIL.SAS7bdat ( Thall and Vail (1990)) Example.
LOGLINK Example #1 SUDAAN Statements and Results Illustrated Log-linear regression modeling MODEL TEST SUBPOPN EFFECTS Input Data Set(s): EPIL.SAS7bdat ( Thall and Vail (1990)) Example Use the Epileptic
More informationModelling the recurrence of bladder cancer
Modelling the recurrence of bladder cancer Gregorio Rubio 1, Cristina Santamaría 1, Belén García 1, and José Luis Pontones 2 1 Matemática multidisciplinar Universidad Politécnica Valencia (Spain) (e-mail:
More informationDesign and Analysis Plan Quantitative Synthesis of Federally-Funded Teen Pregnancy Prevention Programs HHS Contract #HHSP I 5/2/2016
Design and Analysis Plan Quantitative Synthesis of Federally-Funded Teen Pregnancy Prevention Programs HHS Contract #HHSP233201500069I 5/2/2016 Overview The goal of the meta-analysis is to assess the effects
More informationMEA DISCUSSION PAPERS
Inference Problems under a Special Form of Heteroskedasticity Helmut Farbmacher, Heinrich Kögel 03-2015 MEA DISCUSSION PAPERS mea Amalienstr. 33_D-80799 Munich_Phone+49 89 38602-355_Fax +49 89 38602-390_www.mea.mpisoc.mpg.de
More informationPrediction and Inference under Competing Risks in High Dimension - An EHR Demonstration Project for Prostate Cancer
Prediction and Inference under Competing Risks in High Dimension - An EHR Demonstration Project for Prostate Cancer Ronghui (Lily) Xu Division of Biostatistics and Bioinformatics Department of Family Medicine
More informationHow to analyze correlated and longitudinal data?
How to analyze correlated and longitudinal data? Niloofar Ramezani, University of Northern Colorado, Greeley, Colorado ABSTRACT Longitudinal and correlated data are extensively used across disciplines
More informationWorth the weight: Using Inverse Probability Weighted Cox Models in AIDS Research
University of Rhode Island DigitalCommons@URI Pharmacy Practice Faculty Publications Pharmacy Practice 2014 Worth the weight: Using Inverse Probability Weighted Cox Models in AIDS Research Ashley L. Buchanan
More informationThe effect of systemic exposure to efavirenz, sex and age on the risk of virological nonsuppression in HIV-infected African children.
The effect of systemic exposure to efavirenz, sex and age on the risk of virological nonsuppression in HIV-infected African children. Andrzej Bienczak Paolo Denti, Adrian Cook, Veronica Mulenga, Cissy
More informationSupplement for: CD4 cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, gender and calendar time.
Supplement for: CD4 cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, gender and calendar time. Anne Cori* 1, Michael Pickles* 1, Ard van Sighem 2, Luuk Gras 2,
More informationAnalysis of Rheumatoid Arthritis Data using Logistic Regression and Penalized Approach
University of South Florida Scholar Commons Graduate Theses and Dissertations Graduate School November 2015 Analysis of Rheumatoid Arthritis Data using Logistic Regression and Penalized Approach Wei Chen
More informationPSI RESEARCH TOOLKIT. Dashboard Analysis Series Five: Analysis Methodology for Complex Survey Data B UILDING R ESEARCH C APACITY
B UILDING R ESEARCH C APACITY Dashboard Analysis Series Five: Analysis Methodology for Complex Survey Data PSI s Core Values Bottom Line Health Impact * Private Sector Speed and Efficiency * Decentralization,
More informationDesign and Analysis of a Cancer Prevention Trial: Plans and Results. Matthew Somerville 09 November 2009
Design and Analysis of a Cancer Prevention Trial: Plans and Results Matthew Somerville 09 November 2009 Overview Objective: Review the planned analyses for a large prostate cancer prevention study and
More informationT here are an estimated cases of gonorrhoea annually
124 ORIGINAL ARTICLE Gonorrhoea reinfection in heterosexual STD clinic attendees: longitudinal analysis of risks for first reinfection S D Mehta, E J Erbelding, J M Zenilman, A M Rompalo... See end of
More informationA Population-Based Study on the Uptake and Utilization of Stereotactic Radiosurgery (SRS) for Brain Metastasis in Nova Scotia
A Population-Based Study on the Uptake and Utilization of Stereotactic Radiosurgery (SRS) for Brain Metastasis in Nova Scotia Gaurav Bahl, Karl Tennessen, Ashraf Mahmoud-Ahmed, Dorianne Rheaume, Ian Fleetwood,
More informationGALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS
GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS Table of Contents List of authors pag 2 Supplemental figure I pag 3 Supplemental figure II pag 4 Supplemental
More informationMethods to control for confounding - Introduction & Overview - Nicolle M Gatto 18 February 2015
Methods to control for confounding - Introduction & Overview - Nicolle M Gatto 18 February 2015 Learning Objectives At the end of this confounding control overview, you will be able to: Understand how
More informationA Bayesian Perspective on Unmeasured Confounding in Large Administrative Databases
A Bayesian Perspective on Unmeasured Confounding in Large Administrative Databases Lawrence McCandless lmccandl@sfu.ca Faculty of Health Sciences, Simon Fraser University, Vancouver Canada Summer 2014
More informationPeter C. Austin Institute for Clinical Evaluative Sciences and University of Toronto
Multivariate Behavioral Research, 46:119 151, 2011 Copyright Taylor & Francis Group, LLC ISSN: 0027-3171 print/1532-7906 online DOI: 10.1080/00273171.2011.540480 A Tutorial and Case Study in Propensity
More informationTitle: Use of Beta-blockers and Mortality Following Ovarian Cancer Diagnosis: A Population-Based Cohort Study
Author's response to reviews Title: Use of Beta-blockers and Mortality Following Ovarian Cancer Diagnosis: A Population-Based Cohort Study Authors: Sigrun A Johannesdottir (saj@dce.au.dk) Morten Schmidt
More informationINTRODUCTION TO SURVIVAL CURVES
SURVIVAL CURVES WITH NON-RANDOMIZED DESIGNS: HOW TO ADDRESS POTENTIAL BIAS AND INTERPRET ADJUSTED SURVIVAL CURVES Workshop W25, Wednesday, May 25, 2016 ISPOR 21 st International Meeting, Washington, DC,
More informationIntroduction to Survival Analysis Procedures (Chapter)
SAS/STAT 9.3 User s Guide Introduction to Survival Analysis Procedures (Chapter) SAS Documentation This document is an individual chapter from SAS/STAT 9.3 User s Guide. The correct bibliographic citation
More informationMultiple Regression Analysis
Multiple Regression Analysis Basic Concept: Extend the simple regression model to include additional explanatory variables: Y = β 0 + β1x1 + β2x2 +... + βp-1xp + ε p = (number of independent variables
More informationNORTH SOUTH UNIVERSITY TUTORIAL 2
NORTH SOUTH UNIVERSITY TUTORIAL 2 AHMED HOSSAIN,PhD Data Management and Analysis AHMED HOSSAIN,PhD - Data Management and Analysis 1 Correlation Analysis INTRODUCTION In correlation analysis, we estimate
More informationCLASSICAL AND. MODERN REGRESSION WITH APPLICATIONS
- CLASSICAL AND. MODERN REGRESSION WITH APPLICATIONS SECOND EDITION Raymond H. Myers Virginia Polytechnic Institute and State university 1 ~l~~l~l~~~~~~~l!~ ~~~~~l~/ll~~ Donated by Duxbury o Thomson Learning,,
More informationBiomarkers in oncology drug development
Biomarkers in oncology drug development Andrew Stone Stone Biostatistics Ltd EFSPI Biomarkers and Subgroups June 2016 E: andrew@stonebiostatistics.com T: +44 (0) 7919 211836 W: stonebiostatistics.com available
More informationGene expression profiling predicts clinical outcome of prostate cancer. Gennadi V. Glinsky, Anna B. Glinskii, Andrew J. Stephenson, Robert M.
SUPPLEMENTARY DATA Gene expression profiling predicts clinical outcome of prostate cancer Gennadi V. Glinsky, Anna B. Glinskii, Andrew J. Stephenson, Robert M. Hoffman, William L. Gerald Table of Contents
More informationPackage CompareTests
Type Package Package CompareTests February 6, 2017 Title Correct for Verification Bias in Diagnostic Accuracy & Agreement Version 1.2 Date 2016-2-6 Author Hormuzd A. Katki and David W. Edelstein Maintainer
More informationSEQUENTIAL THERAPY IN METASTATIC BREAST CANCER: SURVIVAL ANALYSIS WITH TIME DEPENDENT COVARIATES. Marike Vuga
SEQUENTIAL THERAPY IN METASTATIC BREAST CANCER: SURVIVAL ANALYSIS WITH TIME DEPENDENT COVARIATES by Marike Vuga PhD, Vienna University of Technology, 2001 MS, Graz University of Technology, 1995 Submitted
More informationPerson-years; number of study participants (number of cases) HR (95% CI) P for trend
Table S1: Spearman rank correlation coefficients for cumulative factor score means of dietary and nutrient patterns among adults 18 years and above, the China Health and Nutrition Survey by age and sex
More informationPROCARBAZINE, lomustine, and vincristine (PCV) is
RAPID PUBLICATION Procarbazine, Lomustine, and Vincristine () Chemotherapy for Anaplastic Astrocytoma: A Retrospective Review of Radiation Therapy Oncology Group Protocols Comparing Survival With Carmustine
More informationIndividualized Treatment Effects Using a Non-parametric Bayesian Approach
Individualized Treatment Effects Using a Non-parametric Bayesian Approach Ravi Varadhan Nicholas C. Henderson Division of Biostatistics & Bioinformatics Department of Oncology Johns Hopkins University
More informationTwo-phase designs in epidemiology
Two-phase designs in epidemiology Thomas Lumley March 12, 2018 This document explains how to analyse case cohort and two-phase case control studies with the survey package, using examples from http://faculty.washington.edu/norm/software.
More informationSurvival Analysis in Clinical Trials: The Need to Implement Improved Methodology
Survival Analysis in Clinical Trials: The Need to Implement Improved Methodology Lucinda (Cindy) Billingham Professor of Biostatistics Director, MRC Midland Hub for Trials Methodology Research Lead Biostatistician,
More informationLogistic regression. Department of Statistics, University of South Carolina. Stat 205: Elementary Statistics for the Biological and Life Sciences
Logistic regression Department of Statistics, University of South Carolina Stat 205: Elementary Statistics for the Biological and Life Sciences 1 / 1 Logistic regression: pp. 538 542 Consider Y to be binary
More informationCase Studies in Bayesian Augmented Control Design. Nathan Enas Ji Lin Eli Lilly and Company
Case Studies in Bayesian Augmented Control Design Nathan Enas Ji Lin Eli Lilly and Company Outline Drivers for innovation in Phase II designs Case Study #1 Pancreatic cancer Study design Analysis Learning
More informationWhat you should know before you collect data. BAE 815 (Fall 2017) Dr. Zifei Liu
What you should know before you collect data BAE 815 (Fall 2017) Dr. Zifei Liu Zifeiliu@ksu.edu Types and levels of study Descriptive statistics Inferential statistics How to choose a statistical test
More informationInternet Appendix for. Do Stock Markets Catch the Flu? TABLE A.1. Aggregated and Regional Summary Data
Internet Appendix for Do Stock Markets Catch the Flu? Brian C. McTier, Yiuman Tse, and John K. Wald JOURNAL OF FINANCIAL AND QUANTITATIVE ANALYSIS, Vol. 48, No. 3, June 2013 TABLE A.1 Aggregated and Regional
More information